Advances and Future Perspectives in Biomarkers for Lung Cancer

View Full Paper

Ask AI

Bookmark

Share

Key Points

To discuss the advancements and future perspectives regarding biomarkers in lung cancer treatment.
Overview of molecular diagnostics for non-small cell lung cancer treatment.
Description of singleplex and multiplex genetic testing methods.
Discussion of liquid biopsy as a minimally invasive approach for detecting cancer-related genetic abnormalities.
Emphasis on the importance of biomarkers such as EGFR abnormalities and PD-L1 expression in clinical practice.
Highlighting the transition from singular to multiplex genetic testing in diagnostics.
Recognition of liquid biopsy for its potential to detect minimal residual disease and overcome challenges in tissue diagnosis.

Answers are grounded in this paper and cite their sources.

This overview highlights advances in biomarkers for lung cancer, indicating their critical role in personalized medicine.

No abstract yet. The journal hasn't published one we can show.

No takes yet. Share an insight, caveat, or question.

Masahiro Seike (2025) studied this question.

View Full Paper

Ask AI

Bookmark

Share